Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    11422037 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   EGFR;   HER-2
Intervention: Drug: BIBW 2992
2 Completed
Has Results
Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
Condition: Rash
Interventions: Drug: Minocycline;   Drug: Clindamycin 2% in hydrocortisone 1% lotion;   Drug: Erlotinib;   Drug: Topical clindamycin 2%, triamcinolone acetonide 0.1% soln

Study has passed its completion date and status has not been verified in more than two years.